We pair each portfolio company with a specially crafted, dedicated team of Braveneers and Advisors. Working together in the trenches, we bring specialized experience and expertise to augment portfolio company capabilities, unlock value, and accelerate success.
William is the founder and former lead of BlackRock’s Innovation Capital, the firm’s +$1B venture group. He served as the group’s lead investor and as a trusted advisor to over 25 early- and growth-stage companies with 8 successful IPOs. William spent over a decade at BlackRock and previously held both investment and technical roles at Bridgewater Associates, including Head of Fixed Income Trading Strategy and head architect of the firm’s FX trading system. William also served as founder of LogisticScience, a strategic consulting firm that used advanced data analytics & computational models to support decision making across Fortune 1000 clients.
I founded Braven to tackle opportunities that have meaningful impact on society and deliver outsized financial returns, alongside an exceptional team I genuinely enjoy working with and learning from everyday.
BlackRock, Head of Innovation Capital, Head of Market Intelligence Group, Investment Council Deputy Chair
Bridgewater, Head of Fixed Income Trading Strategy, Trading Systems Architect
LogisticScience, Principal / Founder
Concordia University, Graduate Computer Science
McGill University, B.Sc. in Math and Physiology
LizAnn recently served at the SEC as Deputy Director, Disclosure Operations, for the Division of Corporation Finance where she led a team of ~350 people to fulfill the SEC's mission of investor protection and capital formation. This included assessing emerging risks & helping companies fulfill the disclosure mandates on which investor confidence depends as well as overseeing division-wide risk oversight and innovation. Prior to her tenure at the SEC, LizAnn worked for 20+ years and was a Partner at Cravath, Swaine & Moore LLP, where she focused on domestic and international corporate finance transactions, acquisition financing, corporate governance & reporting matters, and liability management transactions. At present, LizAnn also serves as Acting Professor of the Practice at Cornell Tech/Cornell Law School and as an Adjunct Professor at the University of Oregon law school.
Braven’s disciplined due diligence approach to identifying and cobuilding investments is consistent with the corporate governance and risk management principles I’ve focused on throughout my career.
U.S. Securities and Exchange Commission, Corporation Finance Deputy Director, Disclosure Operations
Cravath, Swaine & Moore LLP, Partner
University of Pennsylvania Carey Law School, Juris Doctor
Cornell University, B.A.
Sean was the CEO of CancerLinQ, a precision oncology enterprise focused on data and advanced analytics. He previously worked at Johnson & Johnson as Global Head of Data Strategy and Data Science and has co-founded two healthtech startups. Sean served as a founding member of the FDA’s Oncology Center of Excellence and as Executive Director and founder of the FDA’s first data science & technology incubator, Information Exchange and Data Transformation (INFORMED). At present, he works as a Research Affiliate at the MIT Laboratory for Financial Engineering and serves on the boards of Society for Translational Oncology, Alliance for Artificial Intelligence in Healthcare, and the Life Sciences Council of the CEO Roundtable on Cancer.
I’ve seen first-hand the challenges healthcare founders face in overcoming systemic obstacles, and I am excited by Braven’s unique, targeted approach to catalyze solution-oriented ecosystems alongside founders."
FDA INFORMED, Founding Executive Director
Johnson & Johnson, VP, Global Head of Data Strategy and Data Science Innovation
National Cancer Institute, Oncologist & Clinical Investigator
University of Maryland, Doctorate of Medicine
The George Washington University, MPH
University of Maryland, B.Sc. in Neuroscience & Physiology
Bradford is one of the preeminent thought-leaders in Talent and Performance, having built modern HR practices from scratch at multiple hyper growth companies. He most recently worked as Chief People Officer at Loadsmart, a Logistics tech unicorn which tripled in valuation and grew from 300 to 800 people in 18 months. Previously, Brad worked as VP, People for Collibra, a B2B SaaS unicorn and as Chief People Officer for Altisource, a publicly traded financial services tech company. He is a frequent keynote at HR conferences, Top 100 HR Influencers (Engagedly), Workforce GameChanger (Top 25 HR under 40), and a Top 100 Emerging Millennial Leader in “Back to Human.” Brad sits on the advisory board of three HR tech companies and of the University of Maryland Smith School of Business Masters in Management program
We have created a ground-breaking talent platform that will enhance every aspect of the team-building process, from selection to assessment to development both internally at Braven and throughout our portfolio companies.
Loadsmart, Chief People Officer
Collibra, Vice President of People
Altisource, Chief People Officer
University of Maryland, B.A. in Theater
Most recently, Joel was the Chief Legal Officer at DRI Capital, where he structured and executed transactions, sat on DRI’s investment committee and led various investments and capital markets transactions, including running the securitization of drug royalties. Joel has also been an executive at Reservoir Media, collaborating in the creation of Reservoir’s music royalty securitization as outside counsel and serving as its Chief Legal Officer during Reservoir’s transformation to a public company. Joel was a partner at Cravath, Swaine & Moore LLP, where he had a broad transactional practice that included leading Cravath’s structured finance practice. Joel has many years of experience in M&A, taking companies public, raising capital and building legal and compliance departments and deep knowledge across a number of industries, including healthcare, industrials, finance and music publishing.
I’ve spent my career focused on regulated industries. I am excited to cobuild companies that will drive meaningful changes in those industries applying Braven’s highly differentiated approach alongside its very talented team.
DRI Capital, EVP and Chief Legal Officer
Reservoir Media Management, Inc, Chief Legal Officer
Cravath, Swaine & Moore LLP, Partner
The George Washington University Law School, JD
William & Mary, B.A.
Margaret most recently worked as a Sr. Associate Consultant at Bain & Company. Her client case work included project scopes such as operating model design and optimization, revenue acceleration, technology planning and customer experience initiatives across a diverse set of industries. In additional to client case work, Margaret led pro-bono cases for the Houston office and managed collaborations between Bain Texas’s Innovation at Bain group and the Bain Innovation Exchange, Bain’s venture ecosystem. She has spent time working on the Strategic Initiatives team at Sanergy, a leading social enterprise in the sanitation and agricultural spaces based in Nairobi, Kenya.
At Braven, I get to combine my passions for analytical problem solving, individual empowerment, and mission driven work - all while working with exceptional, inspiring teammates.
Bain & Company, Senior Associate Consultant
The Sanergy Collaborative, Strategic Initiatives Consultant
The University of Texas at Austin, B.B.A in Business Honors, Finance
Prithvi has extensive experience in the life sciences industry, serving as the Consulting Manager at IQVIA, a leader in advanced analytics, technology solutions, and clinical research services for the global life sciences industry, including pharmaceutical and biotech. In her role, she led engagements focused on managed patient-centered solutions, market access, and portfolio strategy. In her most recent role as Senior Product Manager, Health and Life Sciences at Microsoft + Nuance, Prithvi played a pivotal role in advancing strategic direction and product portfolio, with a specific focus on AI/ML initiatives.
I am energized by our partnerships with extraordinary founders & industry leaders to unlock lasting improvement in a healthcare system that’s ripe with thorny problems.
IQVIA, Engagement Manager, Consulting Services
Microsoft, Senior Product Manager, Health and Life Sciences
COPE Health Solutions, Consultant
Columbia University, Masters in Health Administration
University of Washington, B.Sc. in Psychology
Kiran previously worked as the Financial Strategy Director for health systems & life science clients at Sg2, a premier authority on health care trends, insights, and market analytics. In her role, she developed strategic and financial recommendations and propelled thought leadership for health systems, academic medical centers, and life science clients. Notably, she contributed to the development of an oncology market forecast and leveraged diverse data sources to create business plans for new therapeutics. With experience in medical device startups and a deep understanding of value-based care & clinical trial management, Kiran has collaborated with executives, regulators, & stakeholders across the healthcare ecosystem.
Braven’s collaborative approach to identifying and cobuilding companies that will disrupt healthcare for the better give me tremendous excitement for the future.
Sg2, Director, Financial Strategy
Diagnostic Photonics, Clinical Projects Lead
Salesforce, Business Value Manager
Northwestern University - Kellogg, MBA
Johns Hopkins University, MHS in Immunology and Microbiology
MIT, B.Sc. in Mathematics
For the last five years, Pamela has worked with healthcare providers to help them deliver quality care more effectively and efficiently. As a Strategy & Innovation consultant at HCA Healthcare and a Senior Vice President of Operations at Upperline Health, a national podiatry provider, she gained experience working across internal and external stakeholders and has developed robust understanding of the industry’s complex operating environment. Pamela also has a strong understanding of dynamics surrounding insurance & payment, given her leadership experience at eviCore healthcare. Pamela began her healthcare career at Advisory Board, where she worked in multiple capacities across both the company’s research and consulting practices.
HCA Healthcare, Strategy & Innovation
eviCore healthcare, Director of Operations
Advisory Board, Consultant; Research & Insights Manager
Syracuse University, MBA
The George Washington University, B.A. in Sociology & Organizational Science
Eddie was the first Chief Innovation Officer at CV Starr, a global insurance and investment firm founded by Hank Greenberg, the former Chairman and CEO of AIG. As CIO, Eddie developed the firm’s strategic innovation capabilities and coordinated across firm leadership and investment management committees to develop strategic partnerships with disruptive industry entrants. He has also worked as the Director at JenCap Holdings, a premier MGA, where he led key strategic initiatives including rollup business unit integrations and as the Chief Operating Officer of Scottish American, a national insurance wholesaler. Eddie most recently led innovation strategy and venture portfolio as a general partner at FinMirai, a boutique management consulting group focused on Asia Pacific.
My work involves blending engineering and design thinking with industry expertise to catalyze breakthroughs across the insurance space."
CV Starr, Chief Innovation Officer
JenCap Holdings, Director, Data Analytics and Strategy
FinMirai, Partner, FinTech Strategy and Venture Portfolio
Harvard Business School, MBA
MIT, B.Sc. in Mechanical Engineering
Jeremy is currently completing his Masters of Mathematics at the University of Waterloo, with plans to begin his doctoral studies in 2024. He completed his bachelor’s degree in computer science at Princeton, where he received the Shapiro Prize. Jeremy’s research on combinatorics has been published in Discrete Mathematics and received the journal’s ‘Editor’s Choice Award’ in 2022. In addition to his studies, Jeremy has worked as a software engineer at RestAR where he developed cutting edge 3D modeling software.
As a Braveneer, I apply my background in mathematics and computer science to solve today’s biggest problems in machine learning & next gen computing, working alongside leaders who are shaping the future.
RestAR, Software Research and Development
Goldberg Kohn, Software Developer
Discrete Mathematics, Journal Reviewer
University of Waterloo, Masters in Mathematics - Combinatorics and Optimization
Princeton University, B.S.E. in Computer Science
Adam brings both an academic background in finance and internship experiences at leading venture firms, including Battery Ventures and EPIC Ventures. As a Braven intern, he supports the firm’s intelligence and teams by assisting with research on targeted market opportunities and companies.
Battery Ventures, Analyst Sourcing Extern
EPIC Ventures, Junior Analyst
Turf Kings, Founder
Brigham Young University, B.A. in Finance
Phil has served as a director of White Mountains Insurance Group since 2018. He had previously advised the company on various insurance transactions in a legal capacity while a partner at Cravath, Swaine, & Moore LLP. Philip joined the firm in 1978 and became a partner in 1984. He retired from Cravath’s Corporate Department in December 2017. He has extensive experience in mergers and acquisitions, joint ventures and general corporate counseling. Philip’s practice encompassed complicated negotiated transactions, hostile transactions (both offense and defense), cross-border transactions, activist defense, and advising boards and senior executives, particularly on corporate governance and managing crisis situations. Phil was repeatedly cited as one of the country’s leading practitioners in mergers and acquisitions by, among others, Chambers USA, Chambers Global, The Legal 500 US, IFLR1000 and The Best Lawyers in America.
White Mountains Insurance Group, Director
Cravath, Swaine & Moore LLP, Partner (ret.)
Harvard Law School, JD
Harvard College, A. B.
Prior to her 2016 retirement from Citi as Chief Operations and Technology Officer, Debby was founder and CEO of Citi Ventures, and Citi’s first Chief Innovation Officer. In that role she and her team focused on partnering with emerging cybersecurity and technology companies for deployment in the financial services industry. These partnerships included direct equity investments by Citi Ventures and support to enable the invested companies to scale at an accelerated rate. Prior to Citi, she served as Chief Financial Officer at The Boeing Company and Lucent Technologies. Debby is currently a member of the Board of Directors at Union Pacific, Marsh & McLennan, and Virtusa, and is an Advisory Board Member at M3 Biotechnology Inc., SalesHero and an Executive Fellow at UC Berkeley’s Haas School of Business.
Marsh & McLennan Companies, Board of Director
Citi, Chief Innovation Officer & CEO of Citi Ventures
Boeing, Chief Financial Officer
Walsh College, B.Sc. Accounting
Ross has been associated with HBK since 2014 and is a Managing Director. He serves as HBK’s Chief Technology Officer, with responsibility for software development and IT infrastructure. Ross previously worked as a Managing Director at Goldman, Sachs & Co., where he was responsible for the electronic trading of credit. Prior to that, Ross held technical and managerial positions at Google, Bridgewater Associates and D.E. Shaw. Throughout his career, Ross has stratelled the technical, managerial, and quantitative worlds, possessing a deep understanding of the orchestration required to develop, deploy, and manage new technologies into capital market ecosystems.
HBK, Chief Technology Officer
Google, Software Engineer
Goldman Sachs, Managing Director, Credit Strategist
MIT, Masters and PhD, Mechanical Engineering
MIT, B.Sc., Aeronautics & Astronautics
Bill retired from the FBI in 2019, after 21 years with the organization and leading the Counterintelligence Division from 2015-2018. As head of Counterintelligence, his responsibilities included the development and implementation of the organization’s global strategy to counter foreign nations’ intelligence efforts against the United States. Over his career, Bill has engaged extensively with numerous federal agencies, the National Security Council, the U.S. Congress, international partners, and the private sector. Bill is a co-founder of Trenchcoat Advisors, where he advises Fortune 100 companies and global investment firms on intelligence, risk management, and nation state threat issues. Bill was awarded a National Intelligence Meritorious Unit Citation from the Director of National Intelligence in 2012 and the Meritorious Executive Presidential Rank Award in 2017.
Federal Bureau of Investigation, Head of Counterintelligence
Georgetown University, Adjunct Professor
Trenchcoat Advisors, Co-founder
University of Detroit-Mercy, JD and MBA
Hillsdale College, B.A.
Irving spent 37 years at IBM, where he led a number of IBM’s company wide initiatives including the Internet, supercomputing, and Linux. After retiring from IBM in 2007, he continued to collaborate with the company on major new market strategies like Cloud Computing and Smarter Planet. Irving co-chaired the President’s Information Technology Advisory Committee and was a founding member of the Computer Sciences and Telecommunications Board of the National Research Council. He has worked as an Adviser on Digital Strategy and Innovation at Citigroup, at HBO and at Mastercard. At present, Irving is a Research Affiliate at MIT's Sloan School of Management and at Cybersecurity at MIT Sloan (CAMS) and is a Fellow of the Initiative on the Digital Economy, of MIT Connection Science, and of the Stanford Digital Economy Lab.
IBM, Various leadership roles over 37-year tenure
President’s Information Technology Advisory Committee, Co-Chair
MIT Sloan, Research Affiliate
The University of Chicago, Masters and PhD, Physics